Viewing Study NCT06422533

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:01 AM
Ignite Modification Date: 2026-02-05 @ 6:39 PM
Study NCT ID: NCT06422533
Status: RECRUITING
Last Update Posted: 2024-06-04
First Post: 2024-04-25
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients
Sponsor: Instituto Nacional de Cancerologia de Mexico
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hematologic Neoplasms View
None Neutropenia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ceftolozane/tazobactam View
None piperacillin/tazobactam View
None neutropenia View
None hematologic neoplasms View